Wiley-Blackwell
TopCardiovascular Medicine: Top articles from 2007 and 2008 October 2008
Cardiovascular risk estimation - making sense of the numbers
A Viljoen
A global survey of physicians' perceptions on cholesterol management: the From the Heart study
L Erhardt,
F Hobbs
Estimated 10-year cardiovascular risk in a British population: results of a national screening project
H Neil,
R Perera,
J Armitage,
A Farmer,
D Mant,
P Durrington
Surrogate markers, atherosclerosis and cardiovascular disease prevention
A Wierzbicki
Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting
J Usher-Smith,
T Ramsbottom,
H Pearmain,
M Kirby
Pulmonary hypertension: clinical manifestations, classification and diagnosis
C Elliott,
M Hegewald,
B Markewitz
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension
J Nussberger,
A Gradman,
R Schmieder,
R Lins,
Y Chiang,
M Prescott
Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure
G Fragasso
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely
T Watson,
P Kakar,
G Lip
TopEndocrinology: Top articles from 2007 and 2008 September 2008
Endocrine Incidentalomas
S Jabbour,
M Shirodkar
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
R Shabsigh,
S Arver,
K Channer,
I Eardley,
A Fabbri,
L Gooren,
A Heufelder,
H Jones,
S Meryn,
M Zitzmann
The lean patient with type 2 diabetes: characteristics and therapy challenge
P Brunetti
Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
R Hayes,
J Fitzgerald,
S Jacober
Obesity-hypertension: an ongoing pandemic
E Francischetti,
V Genelhu
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys
H Bays,
R Chapman,
S Grandy (SHIELD Investigators' Group)
Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
S Jabbour,
B Goldstein
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort
A Dornhorst,
H-J Luddeke,
S Sreenan,
C Koenen,
J Hansen,
A Tsur,
L Landstedt-Hallin (PREDICTIVE)
Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
R Scott,
M Wu,
M Sanchez,
P Stein
TopUrology: Most read articles from 2006 and 2007 March 2008
A practical guide to the evaluation of male lower urinary tract symptoms in the primary care setting
M Rosenberg,
D Staskin,
S Kaplan,
S MacDiarmid,
D Newman,
D Ohl
Identification and diagnosis of premature ejaculation
M Rosenberg,
R Sadovsky
Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting
M Naslund,
A Gilsenan,
K Midkiff,
A Bown,
E Wolford,
J Wang
Public, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: a landmark national US survey*
S Kaplan,
M Naslund
Sympton-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial
V Elinoff,
T Bavendam,
D Glasser,
M Carlsson,
N Eyland,
R Roberts
Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study
D Hatzichristou,
J Haro,
A Martin-Morales,
A von Keitz,
A Riley,
J Bertsch,
M Belger,
A Wolka,
A Beardsworth (EDOS Group)
A randomised partially controlled trial to assess the impact of self-help vs. structured help from a continence nurse specialist in women with undiagnosed urinary problems in primary care
A Wagg,
D Barron,
M Kirby,
D Stott,
K Corlett
Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
M Miner,
A Seftel
TopPsychiatry: Most read articles from 2006 and 2007 February 2008
Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
L Citrome,
T Scott Stroup
Clinical assessment and treatment of ADHD in Children
L Smoot,
L Boothby,
R Gillett
Diagnosis and treatment of obsessive-compulsive disorder and related disorders
Bernardo Dell'Osso,
A C Altamura,
E Mundo,
D Marazziti,
E Hollander
Irritable bowel syndrome in psychiatric perspectives: a comprehensive review
C Pae,
P Masand,
N Ajwani,
C Lee,
A Patkar
Issues in the pharmacological treatment of obsessive-compulsive disorder
S Math,
Y Janardhan Reddy
Neurobiology of depression: an integrated view of key findings
V Maletic,
M Robinson,
T Oakes,
S Iyengar,
S Ball,
J Russell
Sequential treatment of depression in primary care
C Rafanelli,
G Fava,
N Sonino
Measuring depressive symptoms in the naturalistic primary-care setting
R McIntyre,
J Konarski,
S Kennedy,
S Dickens,
R Bagby